Ostrum Asset Management »

BioMarin Pharmaceutical shares owned by Ostrum Asset Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Ostrum Asset Management from 13F filings

Historical chart of Ostrum Asset Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Ostrum Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Ostrum Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.1M 35k 87.34
2023-09-30 $3.6M 41k 88.48
2023-06-30 $3.8M 43k 86.68
2023-03-31 $4.2M 44k 97.24
2020-09-30 $1.5M 20k 76.10
2020-06-30 $1.4M 12k 123.30

More positions owned by Ostrum Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corporation Common Stock (NVDA)
Amazon Common Stock (AMZN)
Spdr S&p 500 Etf Tr Exchange Traded Fund (SPY)
Meta Platforms Common Stock (META)
Johnson & Johnson Common Stock (JNJ)
Visa Common Stock (V)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
International Business Machs Common Stock (IBM)
Merck & Co Common Stock (MRK)
Unitedhealth Group Common Stock (UNH)
Eli Lilly & Co Common Stock (LLY)
Cencora Common Stock (COR)

View all positions for Ostrum Asset Management

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
BlackRock
Dodge & Cox
Viking Global Investors
Ameriprise Financial
Barclays
UBS Group
venBio Select Advisor
Elliott Investment Management
Bank of America Corporation
Geode Capital Management
Millennium Management
Bank of New York Mellon
Jpmorgan Chase & Co

View all funds holding BioMarin Pharmaceutical